VVOS News and Press, Vivos Therapeutics Inc. From 11/19/25

2025-11-19 20:34:30 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript ...

2025-11-19 20:33:24 ET Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call November 19, 2025 5:00 PM EST... Read the full article on Seeking Alpha For further details see: Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript

2025-11-19 16:30:19 ET More on Vivos Therapeutics Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript Vivos Therapeutics, Inc. (VVOS) Q2 2025 Earnings Call Transcript Seeking Alpha’s Quant Rating on Vivos Therapeutics H...

Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference call today at 5:00 pm ET to review results and provide operational updates LITTLET...

LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the delivery of highly effective diagnostic procedures and proprietary t...

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

2025-11-04 13:36:29 ET Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call November 4, 2025 12:00 PM EST... Read the full article on Seeking Alpha For further details see: Vivos Therapeutics, Inc. (VVOS) Shareholder/Analyst Call Prepared Remarks Transcript

LITTLETON, Colo., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprieta...

LITTLETON, Colo., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) , a leading medical device and technology company specializing in the development and commercialization of highly effective proprieta...

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...